LISA DUGGAN: Open Payments
NPI 1093789364 · DAHLGREN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 21 payments from 11 companies in 2025. Trend: 2023 $271 · 2024 $486 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $96 |
| ABBVIE INC. | 3 | $56 |
| Lundbeck LLC | 2 | $50 |
| Exact Sciences Corporation | 2 | $46 |
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Amgen Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: REXULTI, Cologuard Collection Kit, QULIPTA, AIRSUPRA, OTEZLA, ZEPBOUND, MOUNJARO, CAPLYTA.
Industry payments across VA — which companies pay providers there.
